Rofecoxib – Engineering Evil

Rofecoxib

Europe says No to drug data access ” arguing that this would undermine commercial interests and that there was no overriding public interest in disclosure”

By Ralph Turchiano on March 30, 2014

Public release date: 10-May-2011 – Request Repost Drug regulators are protecting profits over patients, warn researchers Analysis: Opening up data at the European Medicines Agency Medicines regulators are protecting drug company profits rather than the lives and welfare of patients… Read More ›